Replies to post #172367 on Vivos Inc (RDGL)

[SC8]

We already know report has to be written, which per MK remains in progress. Then report has to undergo a 3rd party review before FDA reviewers have any interest in even bothering with it. All this was already covered in prior RDGL updates. Discussing preliminary results in a meeting isn't a data submission.